These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17339236)

  • 1. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.
    Griffin SC; Barber JA; Manca A; Sculpher MJ; Thompson SG; Buxton MJ; Hemingway H
    BMJ; 2007 Mar; 334(7594):624. PubMed ID: 17339236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.
    Rao C; Aziz O; Panesar SS; Jones C; Morris S; Darzi A; Athanasiou T
    BMJ; 2007 Mar; 334(7594):621. PubMed ID: 17337457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Raab G; Ruckley CV
    Health Technol Assess; 2010 Mar; 14(14):1-210, iii-iv. PubMed ID: 20307380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A UK trial-based cost--utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris.
    Campbell HE; Tait S; Buxton MJ; Sharples LD; Caine N; Schofield PM; Wallwork J
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):312-8. PubMed ID: 11463549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris.
    Campbell HE; Tait S; Sharples LD; Caine N; Gray TJ; Schofield PM; Buxton MJ
    Eur J Health Econ; 2005 Dec; 6(4):288-97. PubMed ID: 16195897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina.
    Henderson RA; Pocock SJ; Sharp SJ; Nanchahal K; Sculpher MJ; Buxton MJ; Hampton JR
    Lancet; 1998 Oct; 352(9138):1419-25. PubMed ID: 9807988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial.
    Weintraub WS; Mahoney EM; Zhang Z; Chu H; Hutton J; Buxton M; Booth J; Nugara F; Stables RH; Dooley P; Collinson J; Stuteville M; Delahunty N; Wright A; Flather MD; De Cock E
    Heart; 2004 Jul; 90(7):782-8. PubMed ID: 15201249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.
    Sharples L; Hughes V; Crean A; Dyer M; Buxton M; Goldsmith K; Stone D
    Health Technol Assess; 2007 Dec; 11(49):iii-iv, ix-115. PubMed ID: 18021576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial.
    Sculpher MJ; Seed P; Henderson RA; Buxton MJ; Pocock SJ; Parker J; Joy MD; Sowton E; Hampton JR
    Lancet; 1994 Oct; 344(8927):927-30. PubMed ID: 7934351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery.
    Reeves BC; Angelini GD; Bryan AJ; Taylor FC; Cripps T; Spyt TJ; Samani NJ; Roberts JA; Jacklin P; Seehra HK; Culliford LA; Keenan DJ; Rowlands DJ; Clarke B; Stanbridge R; Foale R
    Health Technol Assess; 2004 Apr; 8(16):1-43. PubMed ID: 15080865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery.
    Henriksson M; Palmer S; Chen R; Damant J; Fitzpatrick NK; Abrams K; Hingorani AD; Stenestrand U; Janzon M; Feder G; Keogh B; Shipley MJ; Kaski JC; Timmis A; Sculpher M; Hemingway H
    BMJ; 2010 Jan; 340():b5606. PubMed ID: 20085988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary revascularisation: is it ever worth what it costs?
    Mark DB
    Heart; 2007 Oct; 93(10):1161-3. PubMed ID: 17890684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial).
    Amin AP; Reynolds MR; Lei Y; Magnuson EA; Vilain K; Durtschi AJ; Simonton CA; Stone GW; Cohen DJ
    Am J Cardiol; 2012 Sep; 110(6):765-70. PubMed ID: 22651880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.
    Simpson EL; Duenas A; Holmes MW; Papaioannou D; Chilcott J
    Health Technol Assess; 2009 Mar; 13(17):iii, ix-x, 1-154. PubMed ID: 19331797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
    Connock M; Burls A; Frew E; Fry-Smith A; Juarez-Garcia A; McCabe C; Wailoo A; Abrams K; Cooper N; Sutton A; O'Hagan A; Moore D
    Health Technol Assess; 2006 Jul; 10(24):iii-iv, ix-136. PubMed ID: 16796930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
    Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A
    Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Hlatky MA; Boothroyd DB; Melsop KA; Kennedy L; Rihal C; Rogers WJ; Venkitachalam L; Brooks MM;
    Circulation; 2009 Dec; 120(25):2550-8. PubMed ID: 19920002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis for surgical, angioplasty, or medical therapeutics for coronary artery disease: 5-year follow-up of medicine, angioplasty, or surgery study (MASS) II trial.
    Vieira RD; Hueb W; Hlatky M; Favarato D; Rezende PC; Garzillo CL; Lima EG; Soares PR; Hueb AC; Pereira AC; Ramires JA; Kalil Filho R
    Circulation; 2012 Sep; 126(11 Suppl 1):S145-50. PubMed ID: 22965975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.